Logo

American Heart Association

  31
  0


Final ID:

Sex as a modifier of outcomes in genetic cardiomyopathies

  • Tayal, Paz  ( Royal Brompton , London , United Kingdom )
  • Ho, Carolyn  ( Harvard , Boston , Massachusetts , United States )
  • Author Disclosures:
    Paz Tayal: DO NOT have relevant financial relationships | Carolyn Ho: DO have relevant financial relationships ; Consultant:Bristol Myers Squibb:Active (exists now) ; Researcher:Tenaya:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Research Funding (PI or named investigator):Biomarin:Past (completed) ; Research Funding (PI or named investigator):Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Bristol Myers Squib:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Sanofi:Past (completed) ; Consultant:Biomarin:Past (completed) ; Consultant:Lexicon:Active (exists now) ; Consultant:Cytokinetics:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:
More abstracts on this topic:
TTR Amyloidosis: Not so rare in vulnerable populations

Goyal Parag, Argiro Alessia, Arora Pankaj

Bridging the Gap: The Impact of Underrepresentation in Population Biobanks

Clarke Shoa, Bick Alexander, Tcheandjieu Catherine

More abstracts from these authors:
Hypertrophic Cardiomyopathy: Does Genotype Matter?

Ho Carolyn, Parikh Victoria, Raymer David, Sailer Christine

Precision-Based Small Molecule Therapeutics

Ho Carolyn, Ahmad Ferhaan

You have to be authorized to contact abstract author. Please, Login
Not Available